Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3.55%
operating margin TTM
-6.06%
revenue TTM
673.13 Million
revenue per share TTM
5.22$
valuation ratios | |
|---|---|
| pe ratio | -120.73 |
| peg ratio | -0.48 |
| price to book ratio | 3.36 |
| price to sales ratio | 4.31 |
| enterprise value multiple | -536.60 |
| price fair value | 3.36 |
profitability ratios | |
|---|---|
| gross profit margin | 69.6% |
| operating profit margin | -6.06% |
| pretax profit margin | -3.01% |
| net profit margin | -3.55% |
| return on assets | -2.23% |
| return on equity | -2.86% |
| return on capital employed | -4.29% |
liquidity ratios | |
|---|---|
| current ratio | 5.90 |
| quick ratio | 5.42 |
| cash ratio | 4.32 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 100.55 |
| operating cycle | 132.62 |
| days of payables outstanding | 32.76 |
| cash conversion cycle | 99.87 |
| receivables turnover | 11.38 |
| payables turnover | 11.14 |
| inventory turnover | 3.63 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.10 |
| long term debt to capitalization | 0.08 |
| total debt to capitalization | 0.09 |
| interest coverage | -6,450.50 |
| cash flow to debt ratio | 1.57 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.95 |
| cash per share | 4.21 |
| operating cash flow per share | 1.00 |
| free cash flow operating cash flow ratio | 0.96 |
| cash flow coverage ratios | 1.57 |
| short term coverage ratios | 11.28 |
| capital expenditure coverage ratio | 22.67 |
Frequently Asked Questions
When was the last time 10x Genomics, Inc. (NASDAQ:TXG) reported earnings?
10x Genomics, Inc. (TXG) published its most recent earnings results on 08-05-2026.
What is 10x Genomics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. 10x Genomics, Inc. (NASDAQ:TXG)'s trailing twelve months ROE is -2.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. 10x Genomics, Inc. (TXG) currently has a ROA of -2.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TXG's net profit margin stand at?
TXG reported a profit margin of -3.55% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TXG's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.90 in the most recent quarter. The quick ratio stood at 5.42, with a Debt/Eq ratio of 0.10.